Harmony Biosciences Appoints Linda Szyper To Its Board Of Directors

PLYMOUTH MEETING, Pa., Nov. 22, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated toa??developing and commercializing innovative therapies for patients with rare neurological diseases, today announced the appointment of Linda Szyper to the Company's Board of Directors.
Harmony Biosciences Appoints Linda Szyper To Its Board Of Directors
Ms. Szyper brings extensive healthcare and pharmaceutical knowledge with expertise anchored in more than 30 years of experience that spans both pharmaceutical sales and marketing as well as healthcare communications services. Most recently, Ms. Szyper served as the Chief Operating Officer of McCann Health, a global healthcare communications company, where she was responsible for the development and overall operations of the global healthcare network. On Harmony's Board of Directors, she will serve as a member of the Nominating and Corporate Governance Committees."As Harmony aims to bring new treatment options to people living with rare diseases, I look forward to contributing my insights and experience in support of the company's talented team who are working to advance its mission on behalf of patients everywhere," said Ms. Szyper. "I am honored to join Harmony's Board at such a pivotal time of growth for the company and look forward to the opportunity ahead." Prior to joining McCann Health, Ms. Szyper served as Chief Commercial Officer of Circassia, a publicly traded biotechnology and medical device company headquartered in the United Kingdom, from October 2014 to March 2017. In this role she spearheaded business strategy and commercial direction for the organization. Prior to Circassia Pharmaceuticals, she was the Chief Development Officer of Publicis Healthcare Communications Group, a healthcare communications network, from July 1999 to October 2014.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2022    »